Published • loading... • Updated
When Abbott Labs Expects to Close on $23B Takeover of Exact Sciences
The $23 billion deal adds $3 billion in expected 2026 sales and expands Abbott’s leadership in the $60 billion U.S. cancer diagnostics market.
- On March 20, 2026, Abbott said it expects to close its acquisition of Exact Sciences on Monday, March 23, 2026, after receiving all regulatory clearances.
- Abbott announced last year that it would buy Exact Sciences for $23 billion, adding a new growth vertical and establishing leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segments.
- The companies highlighted specific diagnostics such as the Cologuard test, Oncotype DX, Oncodetect MRD test and Cancerguard, with Abbott saying the deal will add about $3 billion of sales in 2026, accelerate growth by 0.5%, and dilute EPS by about $0.20.
- Robert B. Ford said, 'Proactively shaping the portfolio to anticipate future medical needs while building long-term shareholder value remains at the core of our strategic framework' and that the addition of Exact Sciences strengthens Abbott's leadership in diagnostics and cancer screening.
- Abbott's filings caution that the deal may not close on time or at all, warning of integration risks, litigation, regulatory actions, and management distraction as noted in their Annual Report on Form 10-K for the year ended December 31, 2025.
Insights by Ground AI
12 Articles
12 Articles
Wisconsin State JournalReposted by 
Chippewa Herald
Chippewa HeraldAbbott Labs’ $23 billion deal to acquire Madison’s Exact Sciences set to close Monday
The deal is believed to be one of the largest for Abbott in a decade and the largest business investment in the Madison’s history.
·Madison, United States
Read Full Article
Abbott expects to close on acquisition of Madison's Exact Sciences on Monday
Abbott Laboratories expects to close Monday on its acquisition of Madison-based biotechnology company Exact Sciences. The post Abbott expects to close on acquisition of Madison’s Exact Sciences on Monday appeared first on WPR.
·Madison, United States
Read Full Article
Abbott acquisition of Exact Sciences set to close on March 23, 2026
Announcement follows receipt of all regulatory clearances necessary for closingTransaction enables Abbott to enter and lead in fast-growing cancer screening and diagnostics segments, serving millions of additional people
·Pennsylvania, United States
Read Full Article
Coverage Details
Total News Sources12
Leaning Left0Leaning Right0Center10Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
